DK1670773T3 - Fremgangsmåde til fremstilling af benzoxazol-sulfonamidforbindelser og mellemprodukter deraf - Google Patents
Fremgangsmåde til fremstilling af benzoxazol-sulfonamidforbindelser og mellemprodukter derafInfo
- Publication number
- DK1670773T3 DK1670773T3 DK04766869T DK04766869T DK1670773T3 DK 1670773 T3 DK1670773 T3 DK 1670773T3 DK 04766869 T DK04766869 T DK 04766869T DK 04766869 T DK04766869 T DK 04766869T DK 1670773 T3 DK1670773 T3 DK 1670773T3
- Authority
- DK
- Denmark
- Prior art keywords
- benzoxazole
- intermediates
- preparation
- sulfonamide compounds
- sulfonamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03103630 | 2003-09-30 | ||
| US50799603P | 2003-10-02 | 2003-10-02 | |
| PCT/EP2004/052382 WO2005030739A1 (en) | 2003-09-30 | 2004-09-30 | Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1670773T3 true DK1670773T3 (da) | 2007-05-29 |
Family
ID=34395298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04766869T DK1670773T3 (da) | 2003-09-30 | 2004-09-30 | Fremgangsmåde til fremstilling af benzoxazol-sulfonamidforbindelser og mellemprodukter deraf |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20070123574A1 (ja) |
| EP (1) | EP1670773B1 (ja) |
| JP (1) | JP4919802B2 (ja) |
| KR (1) | KR101090102B1 (ja) |
| CN (1) | CN1860107B (ja) |
| AP (1) | AP1985A (ja) |
| AT (1) | ATE353323T1 (ja) |
| AU (1) | AU2004276017B2 (ja) |
| BR (1) | BRPI0414916A (ja) |
| CA (1) | CA2537877C (ja) |
| DE (1) | DE602004004674T2 (ja) |
| DK (1) | DK1670773T3 (ja) |
| EA (1) | EA011891B1 (ja) |
| ES (1) | ES2281828T3 (ja) |
| IL (1) | IL173891A0 (ja) |
| IN (1) | IN2012DN02301A (ja) |
| MX (1) | MXPA06003575A (ja) |
| NO (1) | NO20061951L (ja) |
| NZ (1) | NZ546279A (ja) |
| PL (1) | PL1670773T3 (ja) |
| PT (1) | PT1670773E (ja) |
| SI (1) | SI1670773T1 (ja) |
| WO (1) | WO2005030739A1 (ja) |
| ZA (1) | ZA200602603B (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR053845A1 (es) * | 2005-04-15 | 2007-05-23 | Tibotec Pharm Ltd | 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450 |
| WO2011044134A1 (en) * | 2009-10-05 | 2011-04-14 | Albany Molecular Research, Inc. | Epiminocycloalkyl(b)indole derivatives as serotonin sub-type 6 (5-ht6) modulators and uses thereof |
| AU2012207335A1 (en) | 2011-01-19 | 2013-07-25 | Albany Molecular Research, Inc. | Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia |
| WO2014194519A1 (en) | 2013-06-07 | 2014-12-11 | Merck Sharp & Dohme Corp. | Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968942A (en) * | 1992-08-25 | 1999-10-19 | G. D. Searle & Co. | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| PL184771B1 (pl) * | 1995-03-10 | 2002-12-31 | Searle & Co | Związek stanowiący hydroksyetyloaminosulfonamid pirolidynokarbonyloaminokwasu, kompozycja zawierająca ten związek, jego zastosowanie do wytwarzania kompozycji do leczenia infekcji retrowirusowej i sposób zapobiegania replikacji retrowirusa in vitro |
| AU7722296A (en) * | 1995-11-15 | 1997-06-05 | G.D. Searle & Co. | Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| CA2372352A1 (en) * | 2000-04-07 | 2001-10-18 | Hyun-Gyu Park | Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| US6455738B1 (en) * | 2000-07-13 | 2002-09-24 | Rhodia Chimie | Process for the sulfonation of an aromatic compound |
| ATE343567T1 (de) * | 2001-02-14 | 2006-11-15 | Tibotec Pharm Ltd | Breitspektrum 2-(substituierte-amino)- benzothiazol-sulfonamide hiv protease inhibitoren |
| AU2002310818B2 (en) * | 2001-05-11 | 2007-12-13 | Tibotec Pharmaceuticals Ltd. | Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors |
| AR037797A1 (es) * | 2001-12-12 | 2004-12-01 | Tibotec Pharm Ltd | Combinacion de inhibidores de proteasa dependientes del citocromo p450 |
| MY142238A (en) * | 2002-03-12 | 2010-11-15 | Tibotec Pharm Ltd | Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
-
2004
- 2004-09-30 BR BRPI0414916-5A patent/BRPI0414916A/pt not_active IP Right Cessation
- 2004-09-30 DK DK04766869T patent/DK1670773T3/da active
- 2004-09-30 CA CA2537877A patent/CA2537877C/en not_active Expired - Fee Related
- 2004-09-30 NZ NZ546279A patent/NZ546279A/en not_active IP Right Cessation
- 2004-09-30 PT PT04766869T patent/PT1670773E/pt unknown
- 2004-09-30 EA EA200600699A patent/EA011891B1/ru not_active IP Right Cessation
- 2004-09-30 EP EP04766869A patent/EP1670773B1/en not_active Expired - Lifetime
- 2004-09-30 KR KR1020067005992A patent/KR101090102B1/ko not_active IP Right Cessation
- 2004-09-30 CN CN2004800280971A patent/CN1860107B/zh not_active Expired - Fee Related
- 2004-09-30 ES ES04766869T patent/ES2281828T3/es not_active Expired - Lifetime
- 2004-09-30 PL PL04766869T patent/PL1670773T3/pl unknown
- 2004-09-30 AU AU2004276017A patent/AU2004276017B2/en not_active Ceased
- 2004-09-30 SI SI200430265T patent/SI1670773T1/sl unknown
- 2004-09-30 AT AT04766869T patent/ATE353323T1/de active
- 2004-09-30 IN IN2301DEN2012 patent/IN2012DN02301A/en unknown
- 2004-09-30 JP JP2006530265A patent/JP4919802B2/ja not_active Expired - Fee Related
- 2004-09-30 WO PCT/EP2004/052382 patent/WO2005030739A1/en active IP Right Grant
- 2004-09-30 DE DE602004004674T patent/DE602004004674T2/de not_active Expired - Lifetime
- 2004-09-30 MX MXPA06003575A patent/MXPA06003575A/es active IP Right Grant
- 2004-09-30 AP AP2006003603A patent/AP1985A/xx active
- 2004-09-30 US US10/574,157 patent/US20070123574A1/en not_active Abandoned
-
2006
- 2006-02-22 IL IL173891A patent/IL173891A0/en not_active IP Right Cessation
- 2006-03-29 ZA ZA200602603A patent/ZA200602603B/xx unknown
- 2006-05-02 NO NO20061951A patent/NO20061951L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AP1985A (en) | 2009-03-30 |
| DE602004004674T2 (de) | 2007-11-22 |
| CN1860107B (zh) | 2013-08-21 |
| BRPI0414916A (pt) | 2006-11-07 |
| CN1860107A (zh) | 2006-11-08 |
| CA2537877A1 (en) | 2005-04-07 |
| PT1670773E (pt) | 2007-05-31 |
| KR101090102B1 (ko) | 2011-12-07 |
| CA2537877C (en) | 2015-03-17 |
| AU2004276017B2 (en) | 2010-08-19 |
| EP1670773A1 (en) | 2006-06-21 |
| MXPA06003575A (es) | 2006-06-05 |
| AP2006003603A0 (en) | 2006-04-30 |
| NO20061951L (no) | 2006-05-02 |
| EA200600699A1 (ru) | 2006-08-25 |
| JP2007507468A (ja) | 2007-03-29 |
| IN2012DN02301A (ja) | 2015-08-14 |
| DE602004004674D1 (de) | 2007-03-22 |
| SI1670773T1 (sl) | 2007-06-30 |
| ATE353323T1 (de) | 2007-02-15 |
| ES2281828T3 (es) | 2007-10-01 |
| ZA200602603B (en) | 2008-05-28 |
| EA011891B1 (ru) | 2009-06-30 |
| IL173891A0 (en) | 2006-07-05 |
| AU2004276017A1 (en) | 2005-04-07 |
| JP4919802B2 (ja) | 2012-04-18 |
| KR20060092224A (ko) | 2006-08-22 |
| US20070123574A1 (en) | 2007-05-31 |
| EP1670773B1 (en) | 2007-02-07 |
| PL1670773T3 (pl) | 2007-06-29 |
| NZ546279A (en) | 2008-09-26 |
| WO2005030739A1 (en) | 2005-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1667986T3 (da) | Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf | |
| DK2508521T4 (da) | Dimaleat af en aminocrotonylforbindelse og fremgangsmåde til fremstilling deraf | |
| DK1644384T3 (da) | Fremgangsmåde og mellemprodukter til syntese af entecavir | |
| DK1828164T3 (da) | Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider | |
| DK1778668T3 (da) | Fremgangsmåde til fremstilling af dihydropteridion | |
| DK1656370T3 (da) | Heterocykliske biarylforbindelser og fremgangsmåder til fremstilling og anvendelse af samme | |
| DK1651622T3 (da) | Fremgangsmåde til fremstilling af 2-(quinoxalin-5-ylsulfonylamino)-benzamidforbindelser | |
| DK1840125T3 (da) | Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater | |
| DK1044969T3 (da) | Fremgangsmåde og mellemprodukter til fremstilling af anti-cancer forbindelser | |
| DK1824475T3 (da) | Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol | |
| DK1611108T3 (da) | Fremgangsmåde til fremstilling af telmisartan | |
| DK1546122T3 (da) | Fremgangsmåde til fremstilling af valsartan | |
| DK1831223T3 (da) | Fremgangsmåde til fremstilling af L-biopterin | |
| DK1407037T3 (da) | Fremgangsmåde til fremstilling af tagatose | |
| DK1667967T3 (da) | Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater | |
| NO20052859D0 (no) | Fremgangsmate for fremstilling av resperidon og intermediater derav | |
| DK1353923T3 (da) | Forbedret fremgangsmåde til syntese af carbapenem | |
| DK1578731T3 (da) | Fremgangsmåde til fremstilling af pyrimidinforbindelser | |
| DK1575941T3 (da) | Fremgangsmåde til fremstilling af (S)-pantoprazol | |
| DK1572613T3 (da) | Fremgangsmåde til fremstilling af benzophenoner | |
| DK1678135T3 (da) | Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser | |
| DK1519928T3 (da) | Fremgangsmåde til fremstilling af heterocykliske fluoralkenylsulfoner | |
| DK1727792T3 (da) | Fremgangsmåde til fremstilling af semicarbazoner | |
| DK1692137T3 (da) | Fremgangsmåde til fremstilling af tubulinininhibitorer | |
| DK1802571T3 (da) | Fremgangsmåde og mellemprodukter til fremstilling af derivater af N-(1-benzhydryl-azetidin-3-yl)- N-phenyl-methylsulfonamid |